CSG, Unveils

CSG Unveils Tank Venture and Trident Defence System, But Stock Keeps Dropping to New Lows

Veröffentlicht: 26.06.2026 um 17:55 Uhr, Redaktion boerse-global.de

CSG reveals new tank JV with FNSS, Trident air defence, and North America push at Eurosatory, yet shares hit 52-week low of €12.46, down 30% in a month.

CSG Stock Drops 66% from Peak Despite New Tank JV and Defence Deals
CSG - CSG Unveils Tank Venture and Trident Defence System, But Stock Keeps Dropping to New Lows 26.06.2026 - Bild: ĂĽber boerse-global.de

The Czechoslovak Group (CSG) arrived at the Eurosatory defence fair in Paris this week with a string of announcements that would ordinarily buoy any defence contractor: a new joint venture to manufacture medium tanks, a fresh air?defence system, and a push into the North American market. Yet on the Amsterdam exchange, CSG’s shares have gone into reverse, hitting a fresh 52?week low of €12.20 before edging up to €12.46. Over the past month alone the stock has lost roughly 30% of its value, deepening a slide that began shortly after its record high of €32 on the first day of trading in January.

The centrepiece of CSG’s Eurosatory presence is the creation of Danube Defence Systems, a 50:50 joint venture with Turkish armoured?vehicle specialist FNSS. The new company will produce the CFL?120 Karpat, a medium?weight tank built on the Kaplan?MT platform, marking a significant expansion beyond CSG’s traditional Tatra?based armoured vehicles. The partnership combines Czech engineering with Turkish platform know?how, and the group says it strengthens its ability to win contracts that require both lighter and heavier systems. Separately, CSG also unveiled the Trident air?defence system at the same fair, adding another product to its portfolio.

None of these moves, however, has arrested the sell?off. The stock now trades nearly 66% below its January peak, and technical indicators point to extreme oversold conditions. An RSI reading of 26.6 was recorded earlier in the week, later slipping to as low as 25.5 as selling pressure intensified. Analysts describe a stark decoupling from the fundamentals: CSG recently reaffirmed its full?year guidance, forecasting revenue of around €7.5 billion and an operating margin of 24%. The order backlog stood at €17 billion at the end of the first quarter, providing multi?year visibility on utilisation.

Should investors sell immediately? Or is it worth buying CSG?

Management is also working to broaden the company’s footprint beyond Europe. David Jacobs has been appointed to lead CSG’s North America business, a clear signal of intent to break into the US defence market. On the continent, the group has deepened ties with Ukrainian Armor LLC through a new strategic partnership, while investments in Ukrainian ammunition production and the acquisition of a nitrocellulose plant in Germany underline a push for vertical integration and supply?chain resilience. CEO Michal Strnad has made self?reliance a priority, bringing key manufacturing steps in?house to protect margins.

Despite these strategic milestones, investors appear to be waiting for hard orders rather than promises. The stock’s volatility — measured at around 59% — reflects the nervousness. Some market observers argue that the current valuation looks unduly cheap, pointing to the group’s growth ambitions and stable margins. But they also caution that if the newly announced partnerships and products fail to translate into concrete contracts soon, the share price could breach the €12 threshold, a level that has so far held as technical support.

The broader defence sector has not provided shelter either. While many European arms makers have enjoyed a rerating since Russia’s invasion of Ukraine, CSG has underperformed dramatically, hurt by a combination of weak investor sentiment, concerns over financing at its Tatra Trucks subsidiary, and a perceived lack of near?term catalysts. The recent inclusion of CSG in the Amsterdam AMX Index is expected to improve visibility among institutional investors, but for now the market remains fixated on execution risk rather than the expanding product line.

With over 14,000 employees and a backlog that stretches years into the future, CSG is far from a distressed asset. But the chasm between its operational achievements and its stock price has seldom been wider. The question for shareholders is whether the Eurosatory announcements will eventually be rewarded — or whether the selling pressure will continue until the next batch of quarterly orders provides a tangible reason to buy.

Ad

CSG Stock: New Analysis - 26 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | NL0015073TS8 | CSG | boerse | 69634710 |